Literature DB >> 15116740

Hepatitis C virus ultrastructure and morphogenesis.

Philippe Roingeard1, Christophe Hourioux, Emmanuelle Blanchard, Denys Brand, Malika Ait-Goughoulte.   

Abstract

Details of the ultrastructure of hepatitis C virus (HVC) virion remain unclear because it has proved extremely difficult to visualise virus particles from infected serum and tissues directly. In addition, although much is known about the viral genome, first cloned in 1989, little is known about HCV morphogenesis, due to the lack of an efficient in vitro culture system for HCV propagation. Virus-like particles (VLPs) obtained by expressing genes encoding the HCV structural proteins in mammalian cells can be used as an alternative model for studying HCV morphogenesis. In particular, this HCV-LP model has made it possible to demonstrate that HCV budding occurs at the ER membrane and that the core protein drives this process. The HCV-LP model opens up new possibilities for the investigation of viral morphogenesis and virus-host cell interactions, which may make it possible to establish the long-awaited in vitro culture system for HCV.

Entities:  

Mesh:

Year:  2004        PMID: 15116740     DOI: 10.1016/j.biolcel.2003.11.006

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  20 in total

1.  Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Authors:  Li Ye; Xu Wang; Jieliang Li; Jinping Liu; Servio H Ramirez; Jianguo Wu; Wenzhe Ho
Journal:  Innate Immun       Date:  2011-09-22       Impact factor: 2.680

Review 2.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.

Authors:  Christophe Hourioux; Malika Ait-Goughoulte; Romuald Patient; Delphine Fouquenet; Fabienne Arcanger-Doudet; Denys Brand; Annette Martin; Philippe Roingeard
Journal:  Cell Microbiol       Date:  2006-12-06       Impact factor: 3.715

4.  Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.

Authors:  Pablo Gastaminza; Kelly A Dryden; Bryan Boyd; Malcolm R Wood; Mansun Law; Mark Yeager; Francis V Chisari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Production of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans.

Authors:  Rui Li; Yan Qin; Ying He; Wanyin Tao; Nan Zhang; Cheguo Tsai; Paul Zhou; Jin Zhong
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

7.  Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking.

Authors:  Romuald Patient; Christophe Hourioux; Pierre-Yves Sizaret; Sylvie Trassard; Camille Sureau; Philippe Roingeard
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

8.  Coordinated evolution of the hepatitis C virus.

Authors:  D S Campo; Z Dimitrova; R J Mitchell; J Lara; Y Khudyakov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

9.  Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Authors:  Pablo Gastaminza; Guofeng Cheng; Stefan Wieland; Jin Zhong; Wei Liao; Francis V Chisari
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

10.  Hepatitis C virus budding at lipid droplet-associated ER membrane visualized by 3D electron microscopy.

Authors:  Philippe Roingeard; Christophe Hourioux; Emmanuelle Blanchard; Gérard Prensier
Journal:  Histochem Cell Biol       Date:  2008-05-30       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.